Risultati della ricerca - Danilo Perrotti
- Mostra 1 - 20 risultati su 61
- Vai alla pagina seguente
-
1
-
2
Protein phosphatase 2A: a target for anticancer therapy di Danilo Perrotti, Paolo Neviani
Pubblicazione 2013Revisão -
3
From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies di Maria Ciccone, George A. Călin, Danilo Perrotti
Pubblicazione 2015Revisão -
4
Chronic myeloid leukemia: mechanisms of blastic transformation di Danilo Perrotti, Catriona Jamieson, John M. Goldman, Tomasz Skórski
Pubblicazione 2010Revisão -
5
-
6
Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of<i>bcl</i>-2 promoter activi... di Paolo Salomoni, Danilo Perrotti, Robert Martinez, Claudio Franceschi, Bruno Calabretta
Pubblicazione 1997Artigo -
7
Overexpression of the Zinc Finger Protein MZF1 Inhibits Hematopoietic Development from Embryonic Stem Cells: Correlation with Negative Regulation of <i>CD34</i> and c-<i>myb</i> Pr... di Danilo Perrotti, Paola Melotti, Tomasz Skórski, Ida Casella, C Peschle, Bruno Calabretta
Pubblicazione 1995Artigo -
8
-
9
-
10
-
11
Jak2 inhibition deactivates Lyn kinase through the SET–PP2A–SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients di Abhishek Samanta, Sharmistha Chakraborty, Yingjun Wang, Hagop M. Kantarjian, Xiaoping Sun, John Hood, Danilo Perrotti, Ralph B. Arlinghaus
Pubblicazione 2009Artigo -
12
hnRNP A1 Nucleocytoplasmic Shuttling Activity Is Required for Normal Myelopoiesis and BCR/ABL Leukemogenesis di Angela Iervolino, Giorgia Santilli, Rossana Trotta, Clara Guerzoni, Vincenzo Cesi, Anna Bergamaschi, Carlo Gambacorti‐Passerini, Bruno Calabretta, Danilo Perrotti
Pubblicazione 2002Artigo -
13
-
14
-
15
c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias di Nidal Muvarak, Shannon Kelley, Carine Robert, Maria R. Baer, Danilo Perrotti, Carlo Gambacorti‐Passerini, Curt I. Civin, Kara Scheibner, Feyruz V. Rassool
Pubblicazione 2015Artigo -
16
Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LC-MS/MS method di Zhengyu Liu, Shuang Liu, Zhiliang Xie, William Blum, Danilo Perrotti, Peter Paschka, Rebecca B. Klisovic, John C. Byrd, Karen K. L. Chan, Guido Marcucci
Pubblicazione 2007Artigo -
17
miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eµ-miR-155 transgenic mouse model di Sukhinder K. Sandhu, Stefano Volinia, Stefan Costinean, Marco Galasso, Reid Neinast, Ramasamy Santhanam, Mark R. Parthun, Danilo Perrotti, Guido Marcucci, Ramiro Garzon, Carlo M. Croce
Pubblicazione 2012Revisão -
18
FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma di Qing Liu, Xiaobin Zhao, Frank Frissora, Yihui Ma, Ramasamy Santhanam, David Jarjoura, Amy Lehman, Danilo Perrotti, Ching‐Shih Chen, James T. Dalton, Natarajan Muthusamy, John C. Byrd
Pubblicazione 2007Artigo -
19
TGF-β Utilizes SMAD3 to Inhibit CD16-Mediated IFN-γ Production and Antibody-Dependent Cellular Cytotoxicity in Human NK Cells di Rossana Trotta, Jessica Dal Col, Jianhua Yu, David Ciarlariello, Brittany Thomas, Xiaoli Zhang, Jeffrey Allard, Min Wei, Hsiaoyin Mao, John C. Byrd, Danilo Perrotti, Michael A. Caligiuri
Pubblicazione 2008Artigo -
20
Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia di Michael A. Caligiuri, Roger Briesewitz, Jianhua Yu, Lisheng Wang, Min Wei, Kristy J. Arnoczky, Trent B. Marburger, Jing Wen, Danilo Perrotti, Clara D. Bloomfield, Susan P. Whitman
Pubblicazione 2007Artigo
Strumenti per la ricerca:
Soggetti correlati
Biology
Cancer research
Gene
Cell biology
Genetics
Immunology
Myeloid leukemia
Leukemia
Biochemistry
Molecular biology
Signal transduction
Medicine
Gene expression
Stem cell
microRNA
Cancer
Tyrosine kinase
Receptor
ABL
Internal medicine
Myeloid
Chronic myelogenous leukemia
DNA methylation
Downregulation and upregulation
Haematopoiesis
Transcription factor
Imatinib
Phosphorylation
breakpoint cluster region
Apoptosis